Volasertib + Decitabine in Patients With Acute Myeloid Leukemia (AML)
Condition(s):Leukemia, Myeloid, AcuteLast Updated:January 31, 2019Terminated
Hide Studies Not Open or Pending
Condition(s):Leukemia, Myeloid, AcuteLast Updated:January 31, 2019Terminated
Condition(s):Newly Diagnosed Secondary or High Risk AMLLast Updated:September 8, 2022Completed
Condition(s):Myocardial InfarctionLast Updated:March 31, 2023Active, not recruiting
Condition(s):Healthy VolunteersLast Updated:October 17, 2017Terminated
Condition(s):CancerLast Updated:October 7, 2021Unknown status
Condition(s):InfluenzaLast Updated:June 8, 2018Completed
Condition(s):COPD; Chronic Obstructive Pulmonary Disease; Severe Early-Onset COPD; SEO-COPDLast Updated:February 11, 2020Unknown status
Condition(s):Hemophilia A; Hemophilia BLast Updated:March 26, 2024Recruiting
Condition(s):Older Adults; Gastro-Intestinal Cancer; Prostate Cancer; Lung Cancer; Frail Elderly SyndromeLast Updated:April 13, 2022Enrolling by invitation
Condition(s):Smoldering Multiple MyelomaLast Updated:September 10, 2022Active, not recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.